Resilience Government Services, Inc.
Doing business as Nanotherapeutics Inc. Part of Resilience US Inc.
- UEI
- GC2RFAZK8G64
- CAGE
- 3GQS9
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
DWAQWC7R2DN8
-
Parent
DWAQWC7R2DN8
- SAM.gov registration date
- Website
- resilience.com
- Founded
- 2020
- Employees
- 1K-5K
- Estimated annual revenue
- $500M-$1B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | -$317,102 |
| FY2025 | -$20,090,959 |
| FY2024 | $45,507,032 |
| FY2023 | $34,764,362 |
Contract vehicles
No active vehicles.
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Northwestern University | W911NF2320039 | $89,125 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| On Demand Pharmaceuticals Inc. | Rockville, MD | 325412 Pharmaceutical Preparation Manufacturing |
| Jubilant Hollisterstier LLC | Spokane, WA | 325412 Pharmaceutical Preparation Manufacturing |
| Endo Usa, Inc. | Malvern, PA | 325412 Pharmaceutical Preparation Manufacturing |
| Corporate | Gaithersburg, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Emergent Biosolutions Canada Inc. | Winnipeg, MB | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Resilience Government Services, Inc., doing business as Nanotherapeutics Inc., is a technology focused biomanufacturing company dedicated to broadening access to complex medicines. Founded in 2020, Resilience aims to build a sustainable network of high tech, end to end manufacturing solutions to ensure the medicines of today and tomorrow are reliably supplied.
Through past federal contract awards, Resilience Government Services has provided a range of goods and services related to chemical and biological defense programs, medical countermeasure development, and pharmaceutical manufacturing. As a prime contractor, Resilience has conducted clinical trials, process development and validation, storage and stability testing, prototype development, and manufacturing scale-up across various task orders and contracts with the Department of Defense, specifically the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense, as well as the Department of Health and Human Services National Institutes of Health. Resilience has provided deliverables spanning early stage research through late stage product development, with the goal of achieving FDA licensure for medical countermeasures against biological threats and COVID-19. No set aside designations were indicated on the prime contract awards.
Resilience Government Services currently holds two active Indefinite Delivery Vehicles from the Department of the Army's Acquisition Support Center. A $5.7 million Other Transaction IDIQ aims to transfer existing capabilities to Resilience to demonstrate the provision of medical countermeasures. A $249 million single-award Indefinite Delivery Contract provides an acquisition vehicle for FDA-approved products supporting chemical and biological defense programs. Associated task orders under the IDC advance development and testing of a monoclonal antibody countermeasure through clinical trials and regulatory approval processes.
Quick answers
Is Resilience Government Services, Inc. registered in SAM.gov?
Resilience Government Services, Inc.'s SAM.gov registration expired on February 20, 2026.
Which contract vehicles does Resilience Government Services, Inc. hold?
Resilience Government Services, Inc. holds a place on 2 federal contract vehicles, including Preclinical Services for Biopharmaceutical Product Development and FFMN.
How much has Resilience Government Services, Inc. received in federal contracts?
Federal contracts obligated $59,863,333 to Resilience Government Services, Inc. in fiscal years 2023 through 2027.
What is Resilience Government Services, Inc.'s most recent federal award?
Resilience Government Services, Inc.'s most recent federal contract award is Development of LNA14 analytical methods and upstream and downstream processes for manufacturing, and scale-up… (75N93023F00001), from National Institute of Allergy and Infectious Diseases (NIH), on August 28, 2023.
On GovTribe
See Resilience Government Services, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors